vimarsana.com

Latest Breaking News On - Broderick brian - Page 5 : vimarsana.com

Broderick Brian C Sells 95 Shares of Thermo Fisher Scientific Inc (NYSE:TMO)

Broderick Brian C cut its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 8.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 980 shares of the medical research company’s stock after selling 95 shares during the period. Broderick […]

Broderick Brian C Cuts Stock Holdings in Chevron Co (NYSE:CVX)

Broderick Brian C decreased its holdings in shares of Chevron Co. (NYSE:CVX – Free Report) by 0.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,607 shares of the oil and gas company’s stock after selling 175 shares during the quarter. […]

Broderick Brian C Sells 349 Shares of Alphabet Inc (NASDAQ:GOOGL)

Broderick Brian C cut its stake in Alphabet Inc. (NASDAQ:GOOGL – Get Rating) by 0.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 129,843 shares of the information services provider’s stock after selling 349 shares during the period. Alphabet makes up 3.4% of Broderick Brian […]

Mastercard Incorporated (NYSE:MA) Shares Sold by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC trimmed its position in shares of Mastercard Incorporated (NYSE:MA – Get Rating) by 44.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,803 shares of the credit services provider’s stock after selling 2,208 shares during the period. EverSource Wealth […]

Aptiv PLC (NYSE:APTV) Given Consensus Recommendation of Moderate Buy by Brokerages

Shares of Aptiv PLC (NYSE:APTV – Get Rating) have been assigned a consensus rating of “Moderate Buy” from the sixteen research firms that are currently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month target […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.